Copy Link Print Information

ODN 1826 sodium

(Synonyms: CpG 1826 sodium)
11 Cited Publications
Customer Review

Based on 11 publication(s) in Google Scholar

ODN 1826 sodium is a class B CpG ODN (oligodeoxynucleotide) and TLR9 agonist. ODN 1826 sodium induces NO and iNOS production and enhances Apoptosis. ODN 1826 sodium enhances immune surveillance. ODN 1826 sodium increases aortic atherosclerotic plaque size. ODN 1826 sodium has antitumor activity against lung cancer, glioma and melanoma.

For research use only. We do not sell to patients.

  • Purity: 99.51%
  • Molecular Weight:6364.1 (free acid)
  • Storage:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • ODN 1826 sodium Chemical Structure
    ODN 1826 sodium Chemical Structure
  • Experimental Validation Results for ODN 1826 sodium
  • Experimental Validation Results for ODN 1826 sodium
  • Experimental Validation Results for ODN 1826 sodium
  • Experimental Validation Results for ODN 1826 sodium
  • Experimental Validation Results for ODN 1826 sodium
  • Experimental Validation Results for ODN 1826 sodium
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of ODN 1826 sodium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) ODN 1826 sodium

More
Customer Validation & Images
Cell Proliferation/Viability AssayRT-PCRHistological Imaging/StainingApoptosis AnalysisWB
  • RT-PCR
  • Cell Proliferation/Viability Assay
  • Histological Imaging/Staining
  • Cell Proliferation/Viability Assay
  • Apoptosis Analysis
  • WB

All Toll-like Receptor (TLR) Isoforms

More

All NO Synthase Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • ODN 1826 sodium Chemical Structure
    ODN 1826 sodium Chemical Structure DNA, d(P-thio)(T-C-C-A-T-G-A-C-G-T-T-C-C-T-G-A-C-G-T-T), sodium salt
    1/16
  • 1/16

    ODN 1826 sodium purchased from MedChemExpress. Usage Cited in: Adv Mater. 2025 Sep 1:e02375. [Abstract]

    Customer Validation
     ODN 1826 (CpG, 500 ng per well; 24 h) significantly promoted the repolarization of M2-typed bone marrow-derived cells (BMDM), which stood for tumor-associated macrophages (TAM), with a significant increase of M1 (iNOS) and a decrease of M2 markers (Fizz1 and Mrc1).

  • 1/16

    ODN 1826 sodium purchased from MedChemExpress. Usage Cited in: Life Sci. 2025 Aug 29:380:123930. [Abstract]

    Customer Validation
     Cytotoxicity analysis of DC 2.4 cells treated with DNA-OprF/PcrV + CpG (ODN 1826) for 24 h. CpG was functionally integrated with the DNA vaccine via physical mixing. Specifically, 10 μg of pVAX1-OprF, 10 μg of pVAX1-PcrV, and 10 μg of CpG ODN were vortex-mixed in 150 μl of 1640 medium, followed by the addition of 60 μl of transfection reagent (mass-to-volume ratio = 1:2). The mixture was incubated at room temperature for 30 min to form transfection complexes, sterilized by passage through a 0.22 μm filter, and used immediately.

  • 1/16

    ODN 1826 sodium purchased from MedChemExpress. Usage Cited in: Life Sci. 2025 Aug 29:380:123930. [Abstract]

    Customer Validation
     ODN 1826 (CpG, 0.1 μg/μL; s.c.; 200 μL injected every 2 weeks for a total of three times).
    HE-stained image of pathological sections of the heart, liver, lung, and kidney after immunization (100×). Scale bar = 50 μm. These results revealed no obvious tissue pathological changes or inflammatory cell infiltration in the four treatment groups, including the DNA-OprF/PcrV + CpG group.

  • 1/16

    ODN 1826 sodium purchased from MedChemExpress. Usage Cited in: Neurochem Res. 2025 Sep 5;50(5):288. [Abstract]

    Customer Validation
     ODN 1826 (CpG) regulate astrocyte cell viability and TLR9/NF-κB pathway activation. Human astrocytes were treated with varying concentrations of CpG oligodeoxynucleotides (0, 100, 1000, and 5000 ng/mL) for 24 h. Cell viability was assessed using CCK-8 assay.

  • 1/16

    ODN 1826 sodium purchased from MedChemExpress. Usage Cited in: Neurochem Res. 2025 Sep 5;50(5):288. [Abstract]

    Customer Validation
     ODN 1826 (CpG) regulate astrocyte cell viability and TLR9/NF-κB pathway activation. Human astrocytes were treated with varying concentrations of CpG oligodeoxynucleotides (0, 100, 1000, and 5000 ng/mL) for 24 h. Apoptosis rates were determined by flow cytometry analysis using Annexin V-FITC and propidium iodide staining.

  • 1/16

    ODN 1826 sodium purchased from MedChemExpress. Usage Cited in: Neurochem Res. 2025 Sep 5;50(5):288. [Abstract]

    Customer Validation
     ODN 1826 (CpG) regulate astrocyte cell viability and TLR9/NF-κB pathway activation. Human astrocytes were treated with varying concentrations of CpG oligodeoxynucleotides (0, 100, 1000, and 5000 ng/mL) for 24 h. Protein expression levels of TLR9, total NF-κB, and phosphorylated NF-κB (p-NF-κB) were analyzed by Western blot with GAPDH as loading control.

  • DNA, d(P-thio)(T-C-C-A-T-G-A-C-G-T-T-C-C-T-G-A-C-G-T-T), sodium salt